Abstract:Background Atherosclerosis is considered a crucial component in the pathogenesis of decreased cognitive function, as occurs in vascular cognitive impairment (VCI). Inflammation and the immune response play a significant role in the development of many chronic diseases. Immunoglobulin G (IgG) N -glycosylation has been implicated in the development of a variety of diseases by affecting the anti-inflammatory and proinflammatory responses of IgG. This study aimed to investigate the association between IgG N -glycosylation and VCI in a sample of patients with atherosclerosis through a case-control study. Method We recruited a total of 330 patients with atherosclerosis to participate in this case-control study, including 165 VCI patients and 165 sex- and age-matched participants with normal cognitive function. The plasma IgG N -glycans of participants were separated by ultrahigh-performance liquid chromatography. An enzyme-linked immunosorbent assay (ELISA) kit was used to determine the corresponding serum inflammatory factors. Atherosclerosis was diagnosed by carotid ultrasound, and the diagnosis of VCI was based on the “Guidelines for the Diagnosis and Treatment of Vascular Cognitive Impairment in China (2019)”. A multivariate logistic regression model was used to explore the association between IgG N -glycans and VCI. We also analyzed the relationship between IgG N -glycans and the inflammatory state of VCI through canonical correlation analysis (CCA). Results Through the multivariate logistic regression analysis, 8 glycans and 13 derived traits reflecting decreased sialylation and galactosylation and increased bisecting GlcNAc significantly differed between the case and control groups after adjusting for confounding factors ( P < 0.05, q < 0.05). Similarly, the differences in TNF-α, IL-6, and IL-10 were statistically significant between the case and control groups after adjusting for the effects of confounding factors ( P < 0.05, q < 0.05). The CCA results showed that VCI-related initial N -glycans were significantly correlated with VCI-related inflammatory factors ( r = 0.272, P = 0.004). The combined AUC value (AUC combined = 0.885) of 7 initial glycans and inflammatory factors was higher than their respective values (AUC initial glycans = 0.818, AUC inflammatory factors = 0.773). Conclusion The findings indicate that decreased sialylation and galactosylation and increased bisecting GlcNAc reflected by IgG N -glycans might affect the occurrence of VCI in patients with atherosclerosis though promoting the proinflammatory function of IgG. IgG N -glycans may serve as potential biomarkers to distinguish VCI in individuals with atherosclerosis.

Immunoglobulin G N-glycan Markers of Mild Cognitive Impairment in a Chinese Population with Cerebrovascular Stenosis: A Case-Control Study

Association Between Immunoglobulin G N-glycosylation and Vascular Cognitive Impairment in a Sample With Atherosclerosis: A Case-Control Study

Association of dementia with immunoglobulin G N -glycans in a Chinese Han Population

A Risk Factor Analysis of Cognitive Impairment in Elderly Patients with Chronic Diseases in a Chinese Population

Assessment of the Causal Effect of IgG N-Glycosylation Level on Risk of Dementia: A 2-Sample Mendelian Randomization Study

Identification of Inflammatory and Vascular Markers Associated with Mild Cognitive Impairment.

Predicting psychiatric risk: IgG N-glycosylation traits as biomarkers for mental health

Evaluation of mild cognitive impairment genetic susceptibility risks in a Chinese population

The N-glycosylation of Immunoglobulin G As a Novel Biomarker of Parkinson's Disease.

Glycan biomarkers for Alzheimer disease correlate with T‐tau and P‐tau in cerebrospinal fluid in subjective cognitive impairment

Unravelling the Genetic Causality of Immunoglobulin G N-glycans in Ischemic Stroke

Relationship between plasma lipids and mild cognitive impairment in the elderly Chinese: a case-control study

Serum glial cell line-derived neurotrophic factor: a potential biomarker for white matter alteration in Parkinson's disease with mild cognitive impairment

Glycosylation of IgG Associates with Hypertension and Type 2 Diabetes Mellitus Comorbidity in the Chinese Muslim Ethnic Minorities and the Han Chinese

The Association Between Glymphatic System Dysfunction and Cognitive Impairment in Cerebral Small Vessel Disease

Systematic Review: Immunoglobulin G N-Glycans As Next-Generation Diagnostic Biomarkers for Common Chronic Diseases

Human Brain and Blood N-Glycome Profiling in Alzheimer’s Disease and Alzheimer’s Disease-Related Dementias

Glycomics: Immunoglobulin G<i>N</i>-Glycosylation Associated with Mammary Gland Hyperplasia in Women

Profiling of isomer-specific IgG <i>N</i>-glycosylation in cohort of Chinese colorectal cancer patients

Correlation of mild cognitive impairment with the thickness of retinal nerve fiber layer and serum indicators in type 2 diabetic patients

The correlation between the severity of cerebral microbleeds and serum HMGB1 levels and cognitive impairment in patients with cerebral small vessel disease